Source: Cision

Press Release: BioInvent : BioStock: BioInvent prepares for a data-rich 2025

BioInvent wrapped up 2024 with notable progress across its six clinical programs focusing on the

Read full article »
BioInvent's Competitors | BioInvent's News | BioInvent's Financials
Stay up-to-date with the latest news on BioInvent
Annual Revenue
$25-100M
Employees
25-100
Martin Welschof's photo - President & CEO of BioInvent

President & CEO

Martin Welschof

CEO Approval Rating

92/100

Read more
Stay up-to-date with the latest news on BioInvent